PUBLIC COMPANY
save1st Bio Therapeutics Inc
founded 2016 · 30 employees · Yongin, Gyeonggi-do, KRupdated 1mo ago
1ST Biotherapeutics is a South Korean biopharmaceutical company that discovers and develops first-in-class small-molecule therapeutics. Its pipeline focuses on neurodegenerative diseases, immuno-oncology, and rare diseases, including the HPK1 inhibitor FB-849 in advanced solid tumors and the c-Abl inhibitor FB-101 in alpha-synucleinopathies.
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
comments(0)
5-min edit window · permanent after that